...
moln-img

Molecular Partners AG ADR, Common Stock

MOLN

NSQ

$5.3

+$0.05

(0.95%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$193.53M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
15.98K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.54
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.32 L
$12.7 H
$5.3

About Molecular Partners AG ADR, Common Stock

Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis Pharma AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameMOLNSectorS&P500
1-Week Return-3.81%-2.06%-0.55%
1-Month Return-9.09%-1.92%2.72%
3-Month Return9.5%-10.4%7.66%
6-Month Return-33.42%-4.6%10.15%
1-Year Return21.87%4.06%27.53%
3-Year Return-73.16%1.94%32.31%
5-Year Return-73.03%36.48%89.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue20.38M9.34M9.33M189.56M7.04M[{"date":"2019-12-31","value":10.75,"profit":true},{"date":"2020-12-31","value":4.93,"profit":true},{"date":"2021-12-31","value":4.92,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.71,"profit":true}]
Cost of Revenue43.50M56.08M55.72M50.75M47.84M[{"date":"2019-12-31","value":77.57,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.36,"profit":true},{"date":"2022-12-31","value":90.5,"profit":true},{"date":"2023-12-31","value":85.32,"profit":true}]
Gross Profit(23.11M)(46.73M)(46.39M)138.81M(40.81M)[{"date":"2019-12-31","value":-16.65,"profit":false},{"date":"2020-12-31","value":-33.67,"profit":false},{"date":"2021-12-31","value":-33.42,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-29.4,"profit":false}]
Gross Margin(113.40%)(500.12%)(497.19%)73.23%(579.80%)[{"date":"2019-12-31","value":-154.86,"profit":false},{"date":"2020-12-31","value":-682.96,"profit":false},{"date":"2021-12-31","value":-678.97,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-791.77,"profit":false}]
Operating Expenses57.04M67.67M72.75M72.94M20.30M[{"date":"2019-12-31","value":78.2,"profit":true},{"date":"2020-12-31","value":92.77,"profit":true},{"date":"2021-12-31","value":99.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.83,"profit":true}]
Operating Income(36.66M)(58.33M)(63.42M)116.61M(61.11M)[{"date":"2019-12-31","value":-31.44,"profit":false},{"date":"2020-12-31","value":-50.02,"profit":false},{"date":"2021-12-31","value":-54.38,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-52.4,"profit":false}]
Total Non-Operating Income/Expense1.89M(4.38M)(822.00K)1.76M2.86M[{"date":"2019-12-31","value":65.92,"profit":true},{"date":"2020-12-31","value":-153.11,"profit":false},{"date":"2021-12-31","value":-28.7,"profit":false},{"date":"2022-12-31","value":61.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(36.27M)(62.77M)(63.78M)117.85M(61.98M)[{"date":"2019-12-31","value":-30.78,"profit":false},{"date":"2020-12-31","value":-53.27,"profit":false},{"date":"2021-12-31","value":-54.12,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-52.59,"profit":false}]
Income Taxes17.00K(11.00K)2.00K(1.24M)2.25M[{"date":"2019-12-31","value":0.75,"profit":true},{"date":"2020-12-31","value":-0.49,"profit":false},{"date":"2021-12-31","value":0.09,"profit":true},{"date":"2022-12-31","value":-55.06,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(36.29M)(62.76M)(63.78M)119.09M(64.24M)[{"date":"2019-12-31","value":-30.47,"profit":false},{"date":"2020-12-31","value":-52.7,"profit":false},{"date":"2021-12-31","value":-53.56,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-53.94,"profit":false}]
Income From Continuous Operations(36.29M)(62.76M)(63.78M)117.85M(59.63M)[{"date":"2019-12-31","value":-30.79,"profit":false},{"date":"2020-12-31","value":-53.26,"profit":false},{"date":"2021-12-31","value":-54.12,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-50.6,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(36.29M)(62.76M)(63.78M)117.85M(61.98M)[{"date":"2019-12-31","value":-30.79,"profit":false},{"date":"2020-12-31","value":-53.26,"profit":false},{"date":"2021-12-31","value":-54.12,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-52.59,"profit":false}]
EPS (Diluted)(2.06)(2.56)(2.40)8.25(2.03)[{"date":"2019-12-31","value":-24.99,"profit":false},{"date":"2020-12-31","value":-31.11,"profit":false},{"date":"2021-12-31","value":-29.13,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-24.58,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MOLN
Cash Ratio 13.76
Current Ratio 14.33

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MOLN
ROA (LTM) -21.17%
ROE (LTM) -37.37%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MOLN
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MOLN
Trailing PE NM
Forward PE 1.78
P/S (TTM) 32.24
P/B 1.25
Price/FCF NM
EV/R 4.94
EV/Ebitda 1.23

FAQs

What is Molecular Partners AG ADR share price today?

Molecular Partners AG ADR (MOLN) share price today is $5.3

Can Indians buy Molecular Partners AG ADR shares?

Yes, Indians can buy shares of Molecular Partners AG ADR (MOLN) on Vested. To buy Molecular Partners AG ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MOLN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Molecular Partners AG ADR be purchased?

Yes, you can purchase fractional shares of Molecular Partners AG ADR (MOLN) via the Vested app. You can start investing in Molecular Partners AG ADR (MOLN) with a minimum investment of $1.

How to invest in Molecular Partners AG ADR shares from India?

You can invest in shares of Molecular Partners AG ADR (MOLN) via Vested in three simple steps:

  • Click on Sign Up or Invest in MOLN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Molecular Partners AG ADR shares
What is Molecular Partners AG ADR 52-week high and low stock price?

The 52-week high price of Molecular Partners AG ADR (MOLN) is $12.7. The 52-week low price of Molecular Partners AG ADR (MOLN) is $3.32.

What is Molecular Partners AG ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Molecular Partners AG ADR (MOLN) is

What is Molecular Partners AG ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Molecular Partners AG ADR (MOLN) is 1.25

What is Molecular Partners AG ADR dividend yield?

The dividend yield of Molecular Partners AG ADR (MOLN) is 0.00%

What is the Market Cap of Molecular Partners AG ADR?

The market capitalization of Molecular Partners AG ADR (MOLN) is $193.53M

What is Molecular Partners AG ADR’s stock symbol?

The stock symbol (or ticker) of Molecular Partners AG ADR is MOLN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top